What are the barriers to ctDNA monitoring in endometrial cancer?
Автор: VJOncology
Загружено: 2025-06-18
Просмотров: 33
Описание:
Shannon Westin, MD, FASCO, The University of Texas MD Anderson Cancer Center, and GOG-F, Houston, TX, discusses the current limitations facing the integration of circulating tumor DNA (ctDNA) monitoring in clinical practice across cancer types. Although ctDNA assays are becoming more accessible there is limited research data, particularly for endometrial cancer, which, despite being the most common gynecological malignancy, has been underrepresented in ctDNA research. This interview took place at the 2025 American Society of Clinical Oncology (ASCO) meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
